Abstract
•Sixty-four male individuals (33 in Group-1 and 31 in Group-2) were included.•The mean age and duration of type-2 DM of individuals in groups 1 and 2 were 52.6±0.8 and 54.4±1.2years, and 8.2±0.3years and 10±0.2years, respectively.•BOP and PD showed to significant difference among groups 1 and 2 as compared to baseline.•HbA1c levels were comparable in all groups at all time intervals.
The aim of the present 6-month follow-up study was to assess the effect of mechanical debridement (MD) with adjunct antimicrobial photodynamic therapy (aPDT) in the treatment of peri-implant diseases in type-2 diabetic smokers and non-smokers.
Patients were divided into 2 groups: (a) Group-1: type-2 diabetic smokers; and (b) Group-2: type-2 diabetic non-smokers. In both groups, hemoglobin A1c (HbA1c) levels and peri-implant bleeding on probing (BOP) and probing depth (PD) ≥4mm were measured at baseline and after 6 months of follow-up. Group comparisons were performed using the Kruskall-Wallis test and for multiple comparisons Bonferroni post hoc test was used. Level of significance was set at P<0.05.
Sixty-four individuals (33 in Group-1 and 31 in Group-2) were included. At baseline, BOP and PD≥4mm were comparable among individuals in groups 1 and 2. The mean age of individuals in groups 1 and 2 were 52.6±0.8 and 54.4±1.2years, respectively. The mean duration of type-2 DM among patients in groups 1 and 2 was 8.2±0.3years and 10±0.2years, respectively. In Group-1, the participants were smoking 6.3±1.5 cigarettes daily since 12.7±3.3years. At 6-months follow-up, there was no statistically significant difference in BOP and PD≥4mm among patients in groups 1 and 2 compared with the respective baseline values. HbA1c levels were comparable in all groups at all time intervals
Outcomes of the treatment of periimplant diseases using MD with adjunct aPDT are comparable among type-2 diabetic smokers and non-smokers.